Research Article
Analysis of the Distribution and Antibiotic Resistance of Pathogens Causing Infections in Hospitals from 2017 to 2019
Table 17
Analysis of multiple drug resistance rate of MDR-PAE in 2017.
| | Drugs | Drug resistance rate (%) |
| MDR-PAE | Polymyxin B | 1.3 | | Tobramycin | 19.4 | | Amikacin | 46.6 | | Gentamicin | 69.2 | | Cefoperazone-sulbactam | 81 | | Piperacillin/tazobactam | 93.3 | | Ciprofloxacin | 97.7 | | Piperacillin | 99.3 | | Aztreonam | 99.3 | | Cefepime | 99.7 | | Ceftazidime | 100 | | Imipenem | 100 | | Levofloxacin | 100 |
|
|